Deutsche Bank AG Lowers Stock Holdings in The Chemours Company $CC

Key Points

• Deutsche Bank AG has reduced its stake in The Chemours Company by 42.4%, now holding 49,540 shares valued at $670,000.
• Several institutional investors increased their positions in Chemours, with UMB Bank n.a. raising holdings by 73.9% and Farther Finance Advisors LLC raising by 170.7% during the first quarter.
• Chemours recently announced a quarterly dividend of $0.0875 per share, reflecting an annualized yield of 2.3%, alongside a negative net margin of -7.19% for the latest quarter.

Deutsche Bank AG trimmed its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 42.4% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 49,540 shares of the specialty chemicals company's stock after selling 36,489 shares during the period. Deutsche Bank AG's holdings in Chemours were worth $670,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in CC. Vanguard Group Inc. increased its position in shares of Chemours by 8.3% during the first quarter. Vanguard Group Inc. now owns 16,487,008 shares of the specialty chemicals company's stock valued at $223,069,000 after acquiring an additional 1,263,047 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of Chemours by 23.8% during the fourth quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company's stock valued at $73,907,000 after acquiring an additional 839,849 shares in the last quarter. Millennium Management LLC increased its position in shares of Chemours by 44.6% during the fourth quarter. Millennium Management LLC now owns 2,507,262 shares of the specialty chemicals company's stock valued at $42,373,000 after acquiring an additional 773,537 shares in the last quarter. Balyasny Asset Management L.P. increased its position in shares of Chemours by 90.9% during the fourth quarter. Balyasny Asset Management L.P. now owns 935,031 shares of the specialty chemicals company's stock valued at $15,802,000 after acquiring an additional 445,335 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in shares of Chemours by 116.3% during the first quarter. Principal Financial Group Inc. now owns 742,119 shares of the specialty chemicals company's stock valued at $10,041,000 after acquiring an additional 399,097 shares in the last quarter. Institutional investors own 76.26% of the company's stock.

Chemours Stock Performance

Shares of CC stock traded up $0.31 during mid-day trading on Friday, reaching $15.38. 2,896,747 shares of the company's stock traded hands, compared to its average volume of 4,172,497. The Chemours Company has a 12 month low of $9.13 and a 12 month high of $22.38. The firm has a 50 day moving average price of $13.33 and a two-hundred day moving average price of $12.82. The company has a debt-to-equity ratio of 17.16, a quick ratio of 0.83 and a current ratio of 1.68. The firm has a market capitalization of $2.30 billion, a PE ratio of -5.49 and a beta of 1.61.

Chemours (NYSE:CC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The specialty chemicals company reported $0.58 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.46 by $0.12. Chemours had a negative net margin of 7.19% and a positive return on equity of 35.14%. The firm had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.57 billion. During the same quarter in the previous year, the firm posted $0.38 EPS. The company's revenue for the quarter was up 5.0% compared to the same quarter last year. Chemours has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, research analysts forecast that The Chemours Company will post 2.03 EPS for the current year.

Chemours Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 12th. Stockholders of record on Friday, August 15th will be given a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, August 15th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.3%. Chemours's payout ratio is presently -12.50%.

Insiders Place Their Bets

In other Chemours news, insider Damian Gumpel acquired 7,822 shares of the business's stock in a transaction dated Tuesday, June 3rd. The stock was purchased at an average price of $9.95 per share, with a total value of $77,828.90. Following the transaction, the insider directly owned 131,701 shares in the company, valued at approximately $1,310,424.95. The trade was a 6.31% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Denise Dignam acquired 4,068 shares of the business's stock in a transaction dated Friday, August 8th. The shares were acquired at an average cost of $12.06 per share, with a total value of $49,060.08. Following the transaction, the chief executive officer owned 191,546 shares in the company, valued at approximately $2,310,044.76. This trade represents a 2.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have bought 25,290 shares of company stock valued at $250,437. Insiders own 0.47% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Royal Bank Of Canada raised their price target on shares of Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a research report on Thursday, July 3rd. Zacks Research raised shares of Chemours from a "strong sell" rating to a "hold" rating in a research report on Wednesday. Mizuho raised their price target on shares of Chemours from $13.00 to $16.00 and gave the company an "outperform" rating in a research report on Tuesday, July 15th. Morgan Stanley cut their target price on shares of Chemours from $22.00 to $15.00 and set an "equal weight" rating for the company in a research report on Monday, May 12th. Finally, The Goldman Sachs Group cut their target price on shares of Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Five research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Chemours has an average rating of "Moderate Buy" and a consensus price target of $17.38.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.